November 1, 2023
“…Commercial real estate properties have seen insurance rates rise an average of over 7% since 2017, according to an August Moody’s report. That’s compared to a typical yearly increase of about two to three percent. “It’s not all really due to… Continue Reading…
October 5, 2020
“Bristol-Myers Squibb said on Monday it would buy MyoKardia for about $13 billion to bolster its portfolio of heart disease treatments, as it seeks to reduce some of its dependence on cancer drugs. The deal follows Bristol-Myers’ $74 billion acquisition of Celgene last… Continue Reading…
June 2, 2020
“Pfizer Inc <PFE.N> said on Tuesday it will invest up to $500 million into publicly traded drug developers to fund their treatment candidates and provide access to the U.S. drugmaker’s scientific expertise. Pfizer said it will make non-controlling investments in… Continue Reading…
Recent Comments